Optimization of thrombolytic therapy for acute myocardial infarction involves adjunctive use of aspirin, heparin, and beta-blockers, while routine acute PTCA is not recommended.
No takes yet. Share an insight, caveat, or question.
May warrant adjunctive aspirin, heparin, and beta-blockade in acute MI; leaves open routine acute PTCA utility.
Freek W.A. Verheugt (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: